SYRA
Income statement / Annual
Last year (2024), Syra Health Corp. Class A Common Stock's total revenue was $7.98 M,
an increase of 44.73% from the previous year.
In 2024, Syra Health Corp. Class A Common Stock's net income was -$3.76 M.
See Syra Health Corp. Class A Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$7.98 M |
$5.52 M |
$5.62 M |
$1.41 M |
$0.00 |
| Cost of Revenue |
$6.33 M
|
$4.11 M
|
$4.56 M
|
$979.62 K
|
$0.00
|
| Gross Profit |
$1.65 M
|
$1.41 M
|
$1.06 M
|
$430.35 K
|
$0.00
|
| Gross Profit Ratio |
0.21
|
0.26
|
0.19
|
0.31
|
0
|
| Research and Development Expenses |
$585.15 K
|
$240.05 K
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$4.77 M
|
$4.01 M
|
$3.11 M
|
$416.01 K
|
$0.00
|
| Selling & Marketing Expenses |
-$3.32 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.45 M
|
$4.01 M
|
$3.11 M
|
$416.01 K
|
$4.27 K
|
| Other Expenses |
$3.39 M
|
$52.14 K
|
$45.59 K
|
$17.63 K
|
$0.00
|
| Operating Expenses |
$5.42 M
|
$4.30 M
|
$3.15 M
|
$433.63 K
|
$4.27 K
|
| Cost And Expenses |
$11.75 M
|
$8.40 M
|
$7.71 M
|
$1.41 M
|
$4.27 K
|
| Interest Income |
$21.25 K
|
$2.94 K
|
$63.00
|
$0.00
|
$0.00
|
| Interest Expense |
$15.60 K
|
$53.69 K
|
$28.53 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$62.74 K
|
$48.77 K
|
$14.85 K
|
$207.00
|
$0.00
|
| EBITDA |
-$3.68 M |
-$2.84 M |
-$2.07 M |
-$3.07 K |
-$4.27 K |
| EBITDA Ratio |
-0.46
|
-0.51
|
-0.37
|
-0
|
0
|
| Operating Income Ratio |
-0.47
|
-0.52
|
-0.37
|
-0
|
0
|
| Total Other Income/Expenses Net |
$5.65 K
|
-$50.74 K
|
-$28.47 K
|
$0.00
|
$0.00
|
| Income Before Tax |
-$3.76 M
|
-$2.94 M
|
-$2.12 M
|
-$3.28 K
|
-$4.27 K
|
| Income Before Tax Ratio |
-0.47
|
-0.53
|
-0.38
|
-0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$3.76 M
|
-$2.94 M
|
-$2.12 M
|
-$3.28 K
|
-$4.27 K
|
| Net Income Ratio |
-0.47
|
-0.53
|
-0.38
|
-0
|
0
|
| EPS |
-0.52 |
-0.6 |
-0.36 |
-0.0005 |
-0.0007 |
| EPS Diluted |
-0.52 |
-0.6 |
-0.29 |
-0.0005 |
-0.0007 |
| Weighted Average Shares Out |
$7.26 M
|
$4.88 M
|
$5.86 M
|
$7.28 M
|
$5.98 M
|
| Weighted Average Shares Out Diluted |
$7.26 M
|
$4.88 M
|
$7.28 M
|
$7.28 M
|
$5.98 M
|
| Link |
|
|
|
|
|
